Barrett esophagus: an update

[1]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[2]  Martin Goetz,et al.  Confocal laser endomicroscopy in gastrointestinal diseases , 2011, Journal of biophotonics.

[3]  C. Hawkey,et al.  Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis , 2010, Endoscopy.

[4]  J. Abrams.  Obesity and Barrett’s oesophagus: more than just reflux , 2009, Gut.

[5]  J. Hagen,et al.  Esophageal pH exposure and epithelial cell differentiation. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[6]  G. Lyratzopoulos,et al.  The association between body mass index and Barrett's esophagus: a systematic review. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[7]  Vivek Kaul,et al.  Confocal laser endomicroscopy. , 2009, Gastrointestinal endoscopy.

[8]  R. Odze.  Barrett esophagus: histology and pathology for the clinician , 2009, Nature Reviews Gastroenterology &Hepatology.

[9]  M. Wallace,et al.  Identification of predictive factors for early neoplasia in Barrett's esophagus after autofluorescence imaging: a stepwise multicenter structured assessment. , 2009, Gastrointestinal endoscopy.

[10]  N. Shaheen,et al.  Association of adiponectin multimers with Barrett’s oesophagus , 2009, Gut.

[11]  C. Gheorghe,et al.  Magnifying endoscopy with narrow-band imaging or confocal laser endomicroscopy for in vivo rapid diagnostic of Barrett's esophagus. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[12]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[13]  Mitchell M Lee,et al.  Narrow band imaging in gastroesophageal reflux disease and Barrett's esophagus. , 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[14]  R. Sampliner,et al.  Expression of Bile Acid Transporting Proteins in Barrett's Esophagus and Esophageal Adenocarcinoma , 2009, The American Journal of Gastroenterology.

[15]  R. Hunt,et al.  Helicobacter pylori Infection and Barrett's Esophagus: A Systematic Review and Meta-Analysis , 2009, The American Journal of Gastroenterology.

[16]  S. Ishihara,et al.  Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett’s epithelium development , 2009, Gut.

[17]  G. Falk,et al.  Autofluorescence endoscopy. , 2009, Gastrointestinal endoscopy clinics of North America.

[18]  T. Ang,et al.  The utility of narrow band imaging in improving the endoscopic diagnosis of gastroesophageal reflux disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  Yutaka Saito,et al.  Autofluorescence and narrow-band imaging endoscopy for detecting early-staged cancer in Barrett's esophagus: a case report. , 2008, Japanese journal of clinical oncology.

[20]  Kenneth J. Chang,et al.  Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. , 2008, Gastrointestinal endoscopy.

[21]  Kamran Ayub,et al.  Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study , 2008, Clinical Cancer Research.

[22]  M. Wallace,et al.  Mucosal morphology in Barrett’s esophagus: interobserver agreement and role of narrow band imaging , 2008, Endoscopy.

[23]  P. Moayyedi.  The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview , 2008, Digestive Diseases and Sciences.

[24]  Michael B Wallace,et al.  Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. , 2008, Gastroenterology.

[25]  K. Garsed,et al.  Narrow-band imaging with magnification in Barrett’s esophagus: validation of a simplified grading system of mucosal morphology patterns against histology , 2008, Endoscopy.

[26]  E. Kuipers,et al.  A pro-inflammatory genotype predisposes to Barrett's esophagus. , 2008, Carcinogenesis.

[27]  Thomas Rabenstein,et al.  Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus. , 2008, Gastroenterology.

[28]  P. Ducrotte,et al.  Screening for Esophagitis and Barrett's Esophagus With Wireless Esophageal Capsule Endoscopy: A Multicenter Prospective Trial in Patients With Reflux Symptoms , 2008, The American Journal of Gastroenterology.

[29]  Edward L. Lee,et al.  Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[30]  P. Moayyedi.  Barrett's Esophagus and Obesity: The Missing Part of the Puzzle , 2008, The American Journal of Gastroenterology.

[31]  F. Schmidt.  Meta-Analysis , 2008 .

[32]  N. Hayward,et al.  Leptin and the risk of Barrett’s oesophagus , 2007, Gut.

[33]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[34]  M. Kochman.  Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients , 2008 .

[35]  R. Kiesslich,et al.  Confocal endomicroscopy: in vivo diagnosis of neoplastic lesions of the gastrointestinal tract. , 2008, Anticancer research.

[36]  T. Rokkas,et al.  Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  Alexander Meining,et al.  In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[38]  Kenneth K Wang,et al.  Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett's Esophagus , 2007, The American Journal of Gastroenterology.

[39]  Kenneth K Wang,et al.  Endoscopic tri-modal imaging for detection of early neoplasia in Barrett’s oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system , 2007, Gut.

[40]  C. V. Van Itallie,et al.  Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[41]  R. Fitzgerald,et al.  Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. , 2007, Gastroenterology.

[42]  R. Sampliner,et al.  Activation of the Interleukin-6/STAT3 Antiapoptotic Pathway in Esophageal Cells by Bile Acids and Low pH: Relevance to Barrett's Esophagus , 2007, Clinical Cancer Research.

[43]  E. Steyerberg,et al.  Predicting presence of intestinal metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis. , 2007, Endoscopy.

[44]  B. Overholt,et al.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[45]  M. Bronner,et al.  Central adiposity and risk of Barrett's esophagus. , 2007, Gastroenterology.

[46]  R. Kiesslich,et al.  Technology Insight: confocal laser endoscopy for in vivo diagnosis of colorectal cancer , 2007, Nature Clinical Practice Oncology.

[47]  K. Krishnadath.  Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus , 2007, Current opinion in gastroenterology.

[48]  G. Block,et al.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus. , 2007, Gastroenterology.

[49]  H. Comber,et al.  A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma. , 2007, Carcinogenesis.

[50]  Kenneth K Wang,et al.  Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. , 2007, Gastroenterology.

[51]  Keith Abrams,et al.  Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies , 2007, The American Journal of Gastroenterology.

[52]  Zdenek Kala,et al.  Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett's esophagus , 2007, Journal of Human Genetics.

[53]  R. Poulsom,et al.  Duodenal-content Reflux Into the Esophagus Leads to Expression of Cdx2 and Muc2 in Areas of Squamous Epithelium in Rats , 2007, Journal of Gastrointestinal Surgery.

[54]  A. Shar,et al.  Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. , 2007, Journal of the National Cancer Institute.

[55]  J. Ajani,et al.  Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  J. Tack,et al.  Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces , 2007, Gut.

[57]  Bergein F Overholt,et al.  Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. , 2007, Gastrointestinal endoscopy.

[58]  T. Stephenson,et al.  Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk , 2007, Scandinavian journal of gastroenterology.

[59]  R. Ramirez,et al.  Acid Has Antiproliferative Effects in Nonneoplastic Barrett's Epithelial Cells , 2007, The American Journal of Gastroenterology.

[60]  Peng Wang,et al.  Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. , 2006, Carcinogenesis.

[61]  Fred S. Drennan,et al.  Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. , 2006, Gastrointestinal endoscopy.

[62]  Navtej S Buttar,et al.  Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. , 2007, Gastrointestinal endoscopy.

[63]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[64]  T Rokkas,et al.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.

[65]  R. Sampliner,et al.  Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus , 2006, Gut.

[66]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[67]  P. Thuluvath.  Higher Prevalence and Severity of Hepatic Encephalopathy in Patients with HCV Cirrhosis and Diabetes Mellitus: Is Presence of Autonomic Neuropathy the Missing Part of the Puzzle? , 2006, The American Journal of Gastroenterology.

[68]  J. Borovička,et al.  Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. , 2006, Endoscopy.

[69]  R. Kiesslich,et al.  Confocal laser endoscopy: new approach to the early diagnosis of tumors of the esophagus and stomach. , 2006, Future oncology.

[70]  Paul Fockens,et al.  Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[71]  D. Corley,et al.  Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[72]  R. Playford.  New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus , 2006, Gut.

[73]  A. Bansal,et al.  The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[74]  A. Polglase,et al.  A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract. , 2005, Gastrointestinal endoscopy.

[75]  Kenneth K Wang,et al.  A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. , 2005, Gastroenterology.

[76]  H. El‐Serag,et al.  Abdominal Obesity and the Risk of Barrett's Esophagus , 2005, The American Journal of Gastroenterology.

[77]  H. Bernstein,et al.  Mitochondrial perturbation attenuates bile acid-induced cytotoxicity , 2005, Cell Biology and Toxicology.

[78]  Y. Kadowaki,et al.  Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett’s epithelium , 2005, Gut.

[79]  Markus F Neurath,et al.  Endoscopic confocal imaging. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[80]  Paul Fockens,et al.  Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[81]  H. Bernstein,et al.  Bile acids as carcinogens in human gastrointestinal cancers. , 2005, Mutation research.

[82]  M. Wallace,et al.  Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer , 2004, Alimentary pharmacology & therapeutics.

[83]  S. Spechler,et al.  Review article: what I do now to manage adenocarcinoma risk, and what I may be doing in 10 years' time , 2004, Alimentary pharmacology & therapeutics.

[84]  A. Bhattacharyya,et al.  Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus , 2004, American Journal of Gastroenterology.

[85]  A. Polglase,et al.  Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. , 2004, Gastroenterology.

[86]  B. Shadbolt,et al.  Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus , 2004, The Medical journal of Australia.

[87]  Joseph K McLaughlin,et al.  Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. , 2004, Journal of the National Cancer Institute.

[88]  K. McColl,et al.  Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux , 2004, Gut.

[89]  E. Kuipers,et al.  GI SNAPSHOT , 2003, Gut.

[90]  C. Moskaluk,et al.  Cdx2 as a Marker of Epithelial Intestinal Differentiation in the Esophagus , 2003, The American journal of surgical pathology.

[91]  J. Mant,et al.  Mortality study of 18 000 patients treated with omeprazole , 2003, Gut.

[92]  A. Bhattacharyya,et al.  Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus , 2003, Gut.

[93]  D. Forman,et al.  Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. , 2001, International journal of cancer.

[94]  L. Laine,et al.  Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies , 2002, American Journal of Gastroenterology.

[95]  M. Sivak,et al.  Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults , 2002, Gut.

[96]  Benjamin A. Onwuegbusi,et al.  Inflammatory gradient in Barrett’s oesophagus: implications for disease complications , 2002, Gut.

[97]  P. Malfertheiner,et al.  Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme , 2002, Alimentary pharmacology & therapeutics.

[98]  G. Triadafilopoulos,et al.  Prevalence of Barrett's esophagus in asymptomatic individuals. , 2002, Gastroenterology.

[99]  K. McColl,et al.  Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. , 2002, Gastroenterology.

[100]  D. Schaid,et al.  Barrett's esophagus: prevalence in symptomatic relatives , 2002, American Journal of Gastroenterology.

[101]  J. Seery.  Stem cells of the oesophageal epithelium. , 2002, Journal of cell science.

[102]  Kenneth K Wang,et al.  Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. , 2002, Gastroenterology.

[103]  M. Fennerty.  Barrett's-related esophageal cancer: has the final hurdle been cleared, now paving the way for human chemoprevention trials? , 2002, Gastroenterology.

[104]  R. Fitzgerald,et al.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants , 2002, Gut.

[105]  Fennerty Mb.  Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression? , 2002 .

[106]  M. Fennerty.  Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression? , 2002, Reviews in gastroenterological disorders.

[107]  Z. Halpern,et al.  Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus , 2001, Oncogene.

[108]  A. Axon,et al.  Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. , 2001, Gastroenterology.

[109]  K. McColl,et al.  Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. , 2001, Gastroenterology.

[110]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[111]  S. Attwood,et al.  Cyclooxygenase-2 expression in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence , 2001, American Journal of Gastroenterology.

[112]  E. El-Omar,et al.  Symptomatic benefit 1–3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease , 2000, American Journal of Gastroenterology.

[113]  R. Fitzgerald,et al.  Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. , 1999, Gastroenterology.

[114]  H. Bernstein,et al.  Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate. , 1999, Toxicology letters.

[115]  J. Lagergren,et al.  Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia , 1999, Annals of Internal Medicine.

[116]  S. Riley,et al.  Familial clustering of reflux symptoms , 1999, American Journal of Gastroenterology.

[117]  N. Seersholm,et al.  Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study , 1999, American Journal of Gastroenterology.

[118]  A B West,et al.  An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. , 1998, Cancer research.

[119]  M. Gammon,et al.  Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[120]  D. Schaid,et al.  Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. , 1997, Gastroenterology.

[121]  R. Sandler,et al.  The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.

[122]  E. Funkhouser,et al.  Aspirin and reduced risk of esophageal carcinoma , 1995, Cancer.

[123]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[124]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[125]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[126]  N. L. Johnson,et al.  Multivariate Analysis , 1958, Nature.